rxstatShortages › Peginterferon Alfa-2b Ribavirin

Peginterferon Alfa-2b Ribavirin shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Peginterferon Alfa-2b Ribavirin products have been discontinued in Canada. See the reports below for which products and when.
Products affected
0 / 6
Reports on file
7

Reports by product

Discontinued
PEGETRON
80MCG 200MG · CAPSULE POWDER FOR SOLUTION · MERCK CANADA INC
DIN 02254581
Discontinued
PEGETRON
150MCG 200MG · CAPSULE POWDER FOR SOLUTION · MERCK CANADA INC
DIN 02254646
Discontinued
PEGETRON
120MCG 200MG · CAPSULE POWDER FOR SOLUTION · MERCK CANADA INC
DIN 02254638
Discontinued
PEGETRON
150MCG 200MG · CAPSULE POWDER FOR SOLUTION · MERCK CANADA INC
DIN 02254646
Discontinued
PEGETRON
100MCG 200MG · CAPSULE POWDER FOR SOLUTION · MERCK CANADA INC
DIN 02254603
Discontinued
PEGETRON
150MCG 200MG · CAPSULE POWDER FOR SOLUTION · MERCK CANADA INC
DIN 02246030
Discontinued
PEGETRON
200MG 50MCG · CAPSULE POWDER FOR SOLUTION · MERCK CANADA INC
DIN 02246026

What's happening

One or more Peginterferon Alfa-2b Ribavirin products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Peginterferon Alfa-2b Ribavirin is classified under “IMMUNOSTIMULANTS” (ATC L03AB).

Recent changes

Common questions

When will Peginterferon Alfa-2b Ribavirin be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Peginterferon Alfa-2b Ribavirin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (immunostimulants)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.